Vaccinex, Inc.
VCNX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001205922
No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Vaccinex, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 21 | 25 | +4 |
| Shares | 1.60M | 4.25M | +2.65M (+166.1%) |
| Value | $1.66M | $5.49M | +$3.83M (+230.6%) |
New holders (8)
Institutions that held Vaccinex, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AIGH Capital Management LLC | 2,081,801 | $2.63M | 0.95% |
| Worth Venture Partners, LLC | 66,856 | $88.0K | 0.04% |
| Millennium Management LLC | 30,879 | $41.0K | 0.00% |
| Two Sigma Securities, LLC | 16,823 | $22.0K | 0.00% |
| HRT Financial LP | 16,534 | $21.0K | 0.00% |
| Moors & Cabot, Inc. | 10,000 | $13.0K | 0.00% |
| HNP Capital LLC | 10,000 | $13.0K | 0.00% |
| Royal Bank of Canada | 5,153 | $7.00K | 0.00% |
Sold out (4)
Institutions that held Vaccinex, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Natixis | 31,895 | $33.0K |
| Simplex Trading, LLC | 5,655 | $5.00K |
| Tower Research Capital LLC (TRC) | 3,273 | $3.00K |
| UBS Group AG | 182 | $0 |